LA JOLLA PHARMACEUTICAL CO's ticker is LJPC and the CUSIP is 503459604. A total of 79 filers reported holding LA JOLLA PHARMACEUTICAL CO in Q4 2019. The put-call ratio across all filers is 0.90 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2021 | $63,000 | +10.5% | 14,745 | 0.0% | 0.00% | – |
Q4 2020 | $57,000 | -3.4% | 14,745 | 0.0% | 0.00% | – |
Q3 2020 | $59,000 | -6.3% | 14,745 | 0.0% | 0.00% | – |
Q2 2020 | $63,000 | +1.6% | 14,745 | 0.0% | 0.00% | – |
Q1 2020 | $62,000 | +6.9% | 14,745 | 0.0% | 0.00% | – |
Q4 2019 | $58,000 | -55.4% | 14,745 | 0.0% | 0.00% | – |
Q3 2019 | $130,000 | -4.4% | 14,745 | 0.0% | 0.00% | – |
Q2 2019 | $136,000 | +44.7% | 14,745 | +1.2% | 0.00% | – |
Q1 2019 | $94,000 | -31.4% | 14,575 | 0.0% | 0.00% | – |
Q4 2018 | $137,000 | -53.2% | 14,575 | 0.0% | 0.00% | -100.0% |
Q3 2018 | $293,000 | -31.1% | 14,575 | 0.0% | 0.00% | 0.0% |
Q2 2018 | $425,000 | +24.6% | 14,575 | +27.2% | 0.00% | 0.0% |
Q1 2018 | $341,000 | -7.6% | 11,455 | 0.0% | 0.00% | 0.0% |
Q4 2017 | $369,000 | -6.1% | 11,455 | +1.3% | 0.00% | 0.0% |
Q3 2017 | $393,000 | +16.6% | 11,305 | 0.0% | 0.00% | 0.0% |
Q2 2017 | $337,000 | +24.4% | 11,305 | +24.5% | 0.00% | 0.0% |
Q1 2017 | $271,000 | +25.5% | 9,080 | 0.0% | 0.00% | 0.0% |
Q3 2016 | $216,000 | – | 9,080 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TANG KEVIN C | 240,000 | $1,018,000 | 94.79% |
TANG CAPITAL MANAGEMENT LLC | 9,405,490 | $39,879,000 | 11.22% |
RTW INVESTMENTS, LP | 2,327,903 | $9,870,000 | 0.15% |
Boxer Capital, LLC | 890,700 | $3,777,000 | 0.13% |
FIRST MIDWEST BANK TRUST DIVISION | 89,341 | $379,000 | 0.05% |
WealthTrust Axiom LLC | 30,400 | $128,000 | 0.04% |
PREMIER ASSET MANAGEMENT LLC | 51,305 | $217,000 | 0.04% |
OCCUDO QUANTITATIVE STRATEGIES LP | 18,113 | $77,000 | 0.02% |
HOLLENCREST CAPITAL MANAGEMENT | 39,000 | $165,000 | 0.02% |
Inscription Capital, LLC | 10,000 | $42,000 | 0.01% |